ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 21st, 2012 • Epicept Corp • Pharmaceutical preparations • New York
Seller is the owner of certain patents and trademarks relating to Ceplene in the Territory, as such terms are defined below.
CONSENT AGREEMENTConsent Agreement • June 21st, 2012 • Epicept Corp • Pharmaceutical preparations • Maryland
THIS CONSENT AGREEMENT (this “Agreement”) is dated as of June 18, 2012, by and among EPICEPT CORPORATION, a Delaware corporation (“EpiCept”), MAXIM PHARMACEUTICALS INC., a Delaware corporation (“Maxim”), CYTOVIA, INC., a Delaware corporation (“Cytovia”, and collectively with EpiCept and Maxim, the “Borrowers”), MIDCAP FUNDING III, LLC, a Delaware limited liability company in its capacity as agent (“Agent”) for the lenders under the Loan Agreement (as defined below) (“Lenders”), and the Lenders.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 21st, 2012 • Epicept Corp • Pharmaceutical preparations • New York
Seller desires to sell its rights to Ceplene in the Territory to MEDA, and MEDA desires to purchase such rights to Ceplene in the Territory, all on the terms and conditions set forth in this Agreement.
COOPERATION AGREEMENTCooperation Agreement • June 21st, 2012 • Epicept Corp • Pharmaceutical preparations • New York
NOW THEREFORE, in consideration of the following mutual promises and obligations, and for other good and valuable consideration the adequacy and sufficiency of which are hereby acknowledged, the parties agree as follows:
TERMINATION AGREEMENTTermination Agreement • June 21st, 2012 • Epicept Corp • Pharmaceutical preparations
NOW THEREFORE, in consideration of the following mutual promises and obligations, and for other good and valuable consideration, the adequacy and sufficiency of which are hereby acknowledged, the parties agree as follows:
